Graybill Bartz & Assoc LTD Eli Lilly & CO Transaction History

Graybill Bartz & Assoc LTD

$282 Million
Q2 2025

A detailed history of Graybill Bartz & Assoc LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Graybill Bartz & Assoc LTD holds 868 shares of LLY stock, worth $734,084. This represents 0.24% of its overall portfolio holdings.

Number of Shares

868

Previous 870 0.23%

Holding current value

$734,084

Previous $718,000 5.85%

% of portfolio

0.24%

Previous 0.26%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	SELL	$713.71 - $898.95 $1,427 - $1,797	-2 Reduced 0.23%	868 $676,000
Q1 2025 May 02, 2025	SELL	$725.72 - $929.72 $18,143 - $23,243	-25 Reduced 2.79%	870 $718,000
Q3 2024 Oct 21, 2024	BUY	$772.14 - $960.02 $34,746 - $43,200	45 Added 5.29%	895 $792,000
Q2 2024 Jul 22, 2024	SELL	$724.87 - $909.04 $36,243 - $45,452	-50 Reduced 5.56%	850 $769,000
Q4 2023 Feb 08, 2024	SELL	$525.19 - $619.13 $52,519 - $61,913	-100 Reduced 10.0%	900 $524,000
Q3 2023 Nov 03, 2023	SELL	$434.7 - $599.3 $604,667 - $833,626	-1,391 Reduced 58.18%	1,000 $537,000
Q2 2023 Jul 21, 2023	SELL	$350.74 - $468.98 $61,730 - $82,540	-176 Reduced 6.86%	2,391 $1.12 Million
Q1 2023 Apr 27, 2023	BUY	$310.63 - $364.82 $349,458 - $410,422	1,125 Added 78.02%	2,567 $881,000
Q3 2022 Oct 28, 2022	BUY	$296.48 - $337.87 $14,824 - $16,893	50 Added 3.59%	1,442 $466,000
Q2 2022 Jul 29, 2022	BUY	$278.73 - $327.27 $278 - $327	1 Added 0.07%	1,392 $451,000
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $52,335 - $65,040	223 Added 19.09%	1,391 $398,000
Q3 2021 Oct 22, 2021	SELL	$221.6 - $272.71 $365,640 - $449,971	-1,650 Reduced 58.55%	1,168 $270,000
Q1 2021 Apr 19, 2021	BUY	$164.32 - $212.72 $7,887 - $10,210	48 Added 1.73%	2,818 $526,000
Q4 2020 Jan 20, 2021	SELL	$130.46 - $172.63 $26,092 - $34,526	-200 Reduced 6.73%	2,770 $468,000
Q3 2020 Oct 19, 2020	BUY	$146.22 - $169.13 $87,732 - $101,478	600 Added 25.32%	2,970 $440,000
Q3 2019 Oct 24, 2019	SELL	$106.79 - $116.16 $13,348 - $14,520	-125 Reduced 5.01%	2,370 $265,000
Q2 2019 Jul 25, 2019	SELL	$110.79 - $129.32 $7,755 - $9,052	-70 Reduced 2.73%	2,495 $276,000
Q2 2018 Jul 23, 2018	BUY	$75.7 - $86.88 $194,170 - $222,847	2,565 New	2,565 $219,000
Q1 2018 Apr 18, 2018	SELL	$74.21 - $87.6 $230,644 - $272,260	-3,108 Closed	0 $0
Q3 2017 Oct 18, 2017	BUY	$77.07 - $85.54 $239,533 - $265,858	3,108	3,108 $266,000

Others Institutions Holding LLY

# of Institutions

4,451

Shares Held

780M

Call Options Held

16.5M

Put Options Held

12.2M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $804B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Graybill Bartz & Assoc LTD, based on Form 13F filings with the SEC.

News

Stay updated on Graybill Bartz & Assoc LTD with notifications on news.

Account

Graybill Bartz & Assoc LTD Eli Lilly & CO Transaction History